Mapping the Global Virome. Making the Unknown Known. And the World Safe From a Future of Viral Threats

Size: px
Start display at page:

Download "Mapping the Global Virome. Making the Unknown Known. And the World Safe From a Future of Viral Threats"

Transcription

1 Mapping the Global Virome Making the Unknown Known. And the World Safe From a Future of Viral Threats

2 If you know your enemies and know yourself, you will not be imperiled in a hundred battles;..if you do not know your enemies nor yourself, you will be imperiled in every single battle. Sun Tzu

3 The Problem

4 Number of EVD Events HIV Avian Influenza Nipah SARS H1N1 Zika Ebola MERS We are not prepared! The threat from novel viruses is increasing Actual Projected Each year, approx. 3 new Viral Diseases emerge Driven by Population expansion (1.6 billion in 1900 to 11.5 billion people in 2100) Increased encroachment into wildlife habitat accelerates the spillover of unknown viruses from wildlife to humans Decades Source: Jones et al. (2008) Nature Increasing risk from accidental and/or intentional release of laboratory enhanced viruses

5 The Need

6 To Move From Reactive to Proactive We need to reimagine HOW we understand and prepare for future threats To regard old problems from a new angle requires creative imagination. Albert Einstein

7 The Opportunity

8 We Know There are approximately 1.5 million viruses circulating in wildlife that are unknown a finite universe We can capture and characterize the vast majority of these viruses - turning the unknown into the known We have the ability to use this knowledge convert the sciences of viral diseases into a big data science being transformative and disruptive We can use this information to convert our response to viral threats from reactive to proactive protecting the world from future viral diseases

9 The Solution

10 The Global Virome Project The Global Virome Project (GVP) is a global partnership to transform the sciences of emerging viral diseases by: Developing a global database of virtually all of the planet s naturallyoccurring viral threats Making the world of emerging diseases a data-rich field driving the advanced development of countermeasures, against all future threats

11 GVP Builds a Comprehensive Viral Database GVP viral surveillance and collection Metadata on viral ecology host range, geographic distribution, epidemiology Genomic sequence generation Sequence database Viral Atlas Database A comprehensive ecologic and genetic database on all naturallyoccurring viruses Enabling A Transformative and Disruptive Public Health Tool Box

12 Being Transformative and Disruptive Turning the Sciences of Emerging Viral Disease into Big Data sciences

13 The Approach

14 GVP: Getting to the Source Mammals and water fowl are viral reservoirs Mammalian Habitat ranges Waterfowl breeding hotspots

15 GVP: Mammalian Virome Over 10 years, will target: 68.5% of global mammalian viruses, by sampling 63.5% of global mammalian diversity, to find 71% of mammalian virome 108 Global Sampling Sites Phase 1: 10 countries, 1,562 mammals, $366.4 M Phase 2: 16 countries, 970 mammals, $258 M Phase 3 23 countries, 447 mammals, $132.9 M

16 GVP: Making the Unknown KnownGVP Phase 1: 41% 85% of Global Virome Phase 2: 21% Phase 3: 9% Water fowl: 14%

17 The Impact

18 Impact 1: Development of Broad Countermeasures Converting Virology into a data-rich field SARS Universal Corona Virus Vaccine Thousands of other Corona Viruses MERS GVP will enable the comparative analysis of thousands of members of each viral family and the advanced development of next generation countermeasures that are broadly effective rather than against individual viruses (e.g. MERS, SARS)

19 Impact 2: Pandemic/Epidemic Prevention Drive Targeted, High-Impact Risk Mitigation Minimizing the Risk of Spillover GVP will enable through detailed characterization of every virus's ecologic profile spanning host range, geographic distribution, and epidemiology the identification of viruses that pose the greatest potential threat and the targeting of measures to prevent spillover

20 Parallels to the Human Genome Project An audacious but doable visionary project Clear metrics and goals Disruptive and transformative Can be done in phases where each phase itself generates useful information The potential to change the way we do science and engage global health

21 GVP Organizational Partners include:

22

Identifying, Preparing for & Reducing Pandemic Risk

Identifying, Preparing for & Reducing Pandemic Risk Identifying, Preparing for & Reducing Pandemic Risk Jonna Mazet, DVM, MPVM, PhD Professor of Epidemiology & Disease Ecology One Health Institute School of Veterinary Medicine University of California,

More information

Image of Ebola viruses exiting host cells HUMAN VIRUSES & THE LIMITATION OF ANTIVIRAL DRUG AGENTS

Image of Ebola viruses exiting host cells HUMAN VIRUSES & THE LIMITATION OF ANTIVIRAL DRUG AGENTS Image of Ebola viruses exiting host cells HUMAN VIRUSES & THE LIMITATION OF ANTIVIRAL DRUG AGENTS APRIL 2017 Infectious viruses are a global health threat Since the approval of the first antiviral drug

More information

PREventing EMerging Pathogenic Threats (PREEMPT) Proposers Day

PREventing EMerging Pathogenic Threats (PREEMPT) Proposers Day PREventing EMerging Pathogenic Threats (PREEMPT) Proposers Day Dr. Jim Gimlett, Program Manager DARPA Biological Technologies Office (BTO) January 30, 2018 Arlington, VA PREEMPT Agenda Proposers Day Objectives

More information

Image of Ebola viruses exiting host cells HUMAN VIRUSES & THE LIMITATION OF ANTIVIRAL DRUG AGENTS

Image of Ebola viruses exiting host cells HUMAN VIRUSES & THE LIMITATION OF ANTIVIRAL DRUG AGENTS Image of Ebola viruses exiting host cells HUMAN VIRUSES & THE LIMITATION OF ANTIVIRAL DRUG AGENTS MAY 2017 1 Infectious viral pathogens are a significant global health threat to mankind 2 Since the approval

More information

Blueprint for R&D preparedness and response to public health emergencies due to highly infectious pathogens WORKSHOP ON PRIORITIZATION OF PATHOGENS

Blueprint for R&D preparedness and response to public health emergencies due to highly infectious pathogens WORKSHOP ON PRIORITIZATION OF PATHOGENS Blueprint for R&D preparedness and response to public health emergencies due to highly infectious pathogens WORKSHOP ON PRIORITIZATION OF PATHOGENS 8-9 December 2015 Executive summary On 8-9 December,

More information

July 24, Dr. Dennis Carroll Global Health Bureau Director, Global Health Security and Development. Emerging Threats Program

July 24, Dr. Dennis Carroll Global Health Bureau Director, Global Health Security and Development. Emerging Threats Program Africa Livestock Futures - Through a Lens of Zoonotic Disease Threats: Maximizing the Benefits and Minimizing the Unintended Consequences of Expanded Livestock Production July 24, 2014 Dr. Dennis Carroll

More information

EPIDEMICS AND PANDEMICS: PREDICTION, PREVENTION, CONTROL?

EPIDEMICS AND PANDEMICS: PREDICTION, PREVENTION, CONTROL? 8 th International Conference GLOBAL HEALTH CONSORTIUM Building Alliances in Global Health Miami, May 22-25, 2018 EPIDEMICS AND PANDEMICS: PREDICTION, PREVENTION, CONTROL? José Esparza MD, PhD - Adjunct

More information

PARALLEL SESSION 2.4

PARALLEL SESSION 2.4 PARALLEL SESSION 2.4 CHANGING DYNAMICS: EMERGING INFECTIOUS DISEASES AND ANTIMICROBIAL RESISTANCE IN AN ERA OF EXPANDING GLOBAL HUMAN POPULATION GROWTH AND MOVEMENT BACKGROUND The global human population

More information

CDC s Global Disease Detection Program

CDC s Global Disease Detection Program CDC s Global Disease Program Scott F. Dowell, MD, MPH Division of Global Disease and Emergency Response Centers for Disease Control and Prevention Rationale for Global Disease It would be extremely naïve

More information

WORLD BANK RESPONSE TO INFLUENZA A(H1N1) Rakesh Nangia Director, Strategy & Operations Human Development Network

WORLD BANK RESPONSE TO INFLUENZA A(H1N1) Rakesh Nangia Director, Strategy & Operations Human Development Network WORLD BANK RESPONSE TO INFLUENZA A(H1N1) Rakesh Nangia Director, Strategy & Operations Human Development Network Tokyo, July 2009 World Bank Response to A(H1N1) Influenza A(H1N1) Global Health and Risks

More information

One World One Health: An Economic Perspective

One World One Health: An Economic Perspective 1 One World One Health: An Economic Perspective Beyond Zoonoses: The Threat of Emerging Diseases to Human Security and Conservation, and the Implications for Public Policy James Newcomb Bio Economic Research

More information

Page 1 of 5 For Immediate Release Office of the Press Secretary July 17, 2007 Fact Sheet: Implementation of the National Strategy for Pandemic Influenza A One-Year Summary Of Efforts To Better Protect

More information

Financing international collective action for epidemic & pandemic preparedness

Financing international collective action for epidemic & pandemic preparedness Financing international collective action for epidemic & pandemic preparedness Gavin Yamey MD, MPH Professor of Global Health & Public Policy Director, Center for Policy Impact in Global Health, Duke Global

More information

AZA Research Priorities

AZA Research Priorities AZA Research Priorities Association of Zoos & Aquariums Research & Technology Committee Position Summary: The application of research findings to meet critical needs is a key to the successful accomplishment

More information

Advanced Lecture on One Health

Advanced Lecture on One Health The 6th International Symposium Advanced Lecture on One Health 13:30~16:30 Sept 2, 2013 Lecture Hall, Graduate School of Veterinary Medicine, Hokkaido University, JAPAN Program 13:30~14:30 Dr. Ruben Donis

More information

FAO component of the USAID EPT-2 programme

FAO component of the USAID EPT-2 programme AGENDA FAO component of the USAID EPT-2 programme Working meeting on risk modeling and assessment Rome, Italy 28-30 June 2016 28 June Tuesday 09:00 09:10 Welcome and introduction of participants J. Lubroth

More information

THE EVOLVING LANDSCAPE OF INFECTION PREVENTION: RISK MITIGATION THROUGH INFECTION SURVEILLANCE

THE EVOLVING LANDSCAPE OF INFECTION PREVENTION: RISK MITIGATION THROUGH INFECTION SURVEILLANCE THE EVOLVING LANDSCAPE OF INFECTION PREVENTION: RISK MITIGATION THROUGH INFECTION SURVEILLANCE Yves Crehore Software Product Manager, R.N. RL Solutions AGENDA Current Infectious Landscape Partnership:

More information

Confronting infectious diseases and the role of vaccination: A global perspective KATE ANTEYI. MD, MPH, MBA

Confronting infectious diseases and the role of vaccination: A global perspective KATE ANTEYI. MD, MPH, MBA Confronting infectious diseases and the role of vaccination: A global perspective KATE ANTEYI. MD, MPH, MBA Technical Advisor, United States Agency for International Development (USAID) Chair, WONCA Working

More information

PROCEDURE Follow the instructions as you proceed through the Click and Learn, and answer the questions in the spaces provided.

PROCEDURE Follow the instructions as you proceed through the Click and Learn, and answer the questions in the spaces provided. ABOUT THIS WORKSHEET This worksheet complements the Click and Learn developed in conjunction with the 2016 documentary, Spillover: Zika, Ebola & Beyond (http://www.hhmi.org/biointeractive/virusexplorer).

More information

Broadly protective influenza vaccines for pandemic preparedness. Suresh Mittal Department of Comparative Pathobiology Purdue University

Broadly protective influenza vaccines for pandemic preparedness. Suresh Mittal Department of Comparative Pathobiology Purdue University Broadly protective influenza vaccines for pandemic preparedness Suresh Mittal Department of Comparative Pathobiology Purdue University Influenza A Virus Orthomyxovirus Consist of s/s (-) sense RNA 8 segments

More information

Relations between pathogens, hosts and environment: joining up the dots

Relations between pathogens, hosts and environment: joining up the dots EFSA workshop, EXPO 2015, Milan 16/10/2015 Relations between pathogens, hosts and environment: joining up the dots Prof. Matthew Baylis Liverpool University Climate and Infectious Diseases of Animals Department

More information

Five Major Challenges for Pandemic Prediction and Prevention

Five Major Challenges for Pandemic Prediction and Prevention Five Major Challenges for Pandemic Prediction and Prevention By Peter Daszak Dissecting the Anatomy of a Pandemic Pandemics (diseases that spread globally) are rare events that are often devastating, causing

More information

Center for Global Health. CDC Global Health Saving Lives Overseas, Protecting Americans at Home

Center for Global Health. CDC Global Health Saving Lives Overseas, Protecting Americans at Home Center for Global Health CDC Global Health Saving Lives Overseas, Protecting Americans at Home CDC Overview Part of the U.S. Department of Health and Human Services, CDC is the nation s leading public

More information

Pandemic Preparedness Communications: WHO

Pandemic Preparedness Communications: WHO Pandemic Preparedness Communications: WHO International Ministerial Conference on Avian and Pandemic Influenza, New Delhi, 5 December 2007 WHO Strategic Action Plan: 5 key areas that concern human health

More information

University of Colorado Denver. Pandemic Preparedness and Response Plan. April 30, 2009

University of Colorado Denver. Pandemic Preparedness and Response Plan. April 30, 2009 University of Colorado Denver Pandemic Preparedness and Response Plan April 30, 2009 UCD Pandemic Preparedness and Response Plan Executive Summary The World Health Organization (WHO) and the Centers for

More information

The Threat of Agroterrorism and Zoonotic Diseases in the United States

The Threat of Agroterrorism and Zoonotic Diseases in the United States The Threat of Agroterrorism and Zoonotic Diseases in the United States Gary Alan Flory Gary.Flory@deq.virginia.gov http://garyflory.com Virginia Department of Environmental Quality, VA 22801, USA Written

More information

MERS H7N9. coronavirus. influenza virus. MERS: Since September 2012: 160 cases, including 68 deaths (42%)

MERS H7N9. coronavirus. influenza virus. MERS: Since September 2012: 160 cases, including 68 deaths (42%) MERS coronavirus H7N9 influenza virus Marc Van Ranst, KU Leuven MERS: Since September 2012: 160 cases, including 68 deaths (42%) MERS coronavirus patient, 83 years, Saudi-Arabia H7N9: Since February 2013:

More information

Preventing disease Promoting and protecting health

Preventing disease Promoting and protecting health Preventing disease Promoting and protecting health CONTENTS Context Global Health Security what is it? Health security the perfect storm Regional Health Security what is it? Caribbean Regional Health Security:

More information

Emerging global health threats of animal origin

Emerging global health threats of animal origin Emerging global health threats of animal origin Ahmed El Idrissi Senior Officer Transboundary Animal Diseases and zoonoses Animal Production and Health Division FAO - Rome 9 th meeting of the REMESA JPC

More information

Progress report on emerging and re-emerging diseases including dengue and dengue haemorrhagic fever

Progress report on emerging and re-emerging diseases including dengue and dengue haemorrhagic fever Regional Committee for the Eastern Mediterranean Sixty-third session Provisional agenda item 3(c) EM/RC63/INF.DOC 2 Rev.2 September 2016 Introduction Progress report on emerging and re-emerging diseases

More information

FAO contribution to the OFFLU swine influenza group

FAO contribution to the OFFLU swine influenza group FAO contribution to the OFFLU swine influenza group Filip Claes, Gwenaelle Dauphin EMPRES laboratory unit Paris, 27-28 March 2012 2011 2012 Spotted any difference? Content Contribution to SIV surveillance

More information

What is influenza virus? 13,000 base RNA genome: 1/ the size of the human genome

What is influenza virus? 13,000 base RNA genome: 1/ the size of the human genome What is influenza virus? 13,000 base RNA genome: 1/246153 the size of the human genome CDC Principles of Virology, 4e Neumann et al. Nature. 2009. Influenza virus is one of the most deadly viral pathogens

More information

Global Pandemic Preparedness Research Efforts. Klaus Stöhr. WHO Global Influenza Programme. Today

Global Pandemic Preparedness Research Efforts. Klaus Stöhr. WHO Global Influenza Programme. Today Global Pandemic Preparedness Research Efforts Klaus Stöhr 3 Today Medium-term applied research linked to medical and public health interventions addressing the current pandemic situation in Asia Natural

More information

Killer Viruses: The Why and The How. Amesh Adalja

Killer Viruses: The Why and The How. Amesh Adalja Killer Viruses: The Why and The How Amesh Adalja MD @AmeshAA Disclosures Stockholder: Merck, Luminex, Evolent Bondholder: UPMC Speaker s Bureau: Merck, Roche Consultant: Roche Funding: Open Philanthropy

More information

OPPORTUNITIES FOR HHS & DOD COLLABORATION FOR MEDICAL COUNTERMEASURES

OPPORTUNITIES FOR HHS & DOD COLLABORATION FOR MEDICAL COUNTERMEASURES OPPORTUNITIES FOR HHS & DOD COLLABORATION FOR MEDICAL COUNTERMEASURES Dr. Robert P. Kadlec Assistant Secretary for Preparedness and Response U.S. Department of Health and Human Services 2017 Chemical and

More information

USDA APHIS One Health Initiative

USDA APHIS One Health Initiative Biorisk Management in a One Health World USDA APHIS One Health Initiative Joseph F. Annelli, DVM, MS One Health Coordination Center U.S. Department of Agriculture Animal and Plant Health Inspection Service

More information

7th Mena Influenza Stakeholders Meeting. WHO Influenza Strategy Development and Vaccine-related Research Priorities

7th Mena Influenza Stakeholders Meeting. WHO Influenza Strategy Development and Vaccine-related Research Priorities 7th Mena Influenza Stakeholders Meeting WHO Influenza Strategy Development and Vaccine-related Research Priorities Wenqing Zhang 9 10 September 2017 Riga, Latvia 1 Seasonal influenza 1 billion cases yearly

More information

Influenza Pandemic Preparedness for Clinicians on the Frontline

Influenza Pandemic Preparedness for Clinicians on the Frontline Influenza Pandemic Preparedness for Clinicians on the Frontline CAPT HA C. TANG, DO US Public Health Service Adjunct Associate Clinical Professor of Dartmouth Medical School, Community/Family Medicine

More information

Planning for Pandemic Influenza in York County: Considerations for Healthcare and Medical Response

Planning for Pandemic Influenza in York County: Considerations for Healthcare and Medical Response Planning for Pandemic Influenza in York County: Considerations for Healthcare and Medical Response York County Pandemic Influenza Stakeholders Village by the Sea, Wells, Maine 8 August 2006 Steven J Trockman,

More information

World Health Report 2019 Predictions

World Health Report 2019 Predictions World Health Report 2019 Predictions EBOLA I Predictions for Ebola in the DRC As the number of cases of Ebola in the Democratic Republic of Congo approaches 550, and fatalities almost 320, it is clear

More information

Public Health Management and Preparedness in Wildlife Zoonotic Disease Outbreak

Public Health Management and Preparedness in Wildlife Zoonotic Disease Outbreak Johor Bahru Health Office Public Health Management and Preparedness in Wildlife Zoonotic Disease Outbreak Dr. Badrul Hisham bin Abd. Samad MBBS (Malaya), MPH (Glasgow), M. Environmental Engineering (UTM),

More information

Global and Regional Strategies for HPAI and CSF

Global and Regional Strategies for HPAI and CSF Global and Regional Strategies for HPAI and CSF 2 Key Strategic Approach Strengthening of Veterinary Services and related national capacity, including compliance with OIE standards and guidelines on quality

More information

CIDRAP Leadership Forum Infectious Disease BRIEFING

CIDRAP Leadership Forum Infectious Disease BRIEFING Center for Infectious Disease Research and Policy University of Minnesota CIDRAP Leadership Forum Infectious Disease BRIEFING December 13 th, 2017 CLF BRIEFING HOT TOPICS 1. Influenza (surveillance, vaccine,

More information

Where Health Care Meets Policy. with Dr. Mike Magee

Where Health Care Meets Policy. with Dr. Mike Magee Where Health Care Meets Policy with Dr. Mike Magee The Threat of Bird Flu Understanding Bird Flu and the Influenza Virus 3 types of the influenza virus: A, B and C reflect differences in the M protein

More information

Proliferation Threats from Biotechnology: What is Dual-Use Research?

Proliferation Threats from Biotechnology: What is Dual-Use Research? Proliferation Threats from Biotechnology: What is Dual-Use Research? In Class Discussion Break into groups of 3, come up with definition dual use and present to class Biological Dual-Use Research Biotechnology

More information

Introduction. Chapter 7 Protecting Animal Health. Implementation Plan for the National Strategy for Pandemic Influenza 137

Introduction. Chapter 7 Protecting Animal Health. Implementation Plan for the National Strategy for Pandemic Influenza 137 Chapter 7 Protecting Animal Health Introduction Influenza viruses that cause severe disease outbreaks in animals, especially birds, are believed to be a likely source for the emergence of a human pandemic

More information

On behalf of the Infectious Diseases Society of America (IDSA), I offer testimony in

On behalf of the Infectious Diseases Society of America (IDSA), I offer testimony in Testimony of the Infectious Diseases Society of America (IDSA) on the Fiscal Year 2018 Department of Health and Human Services Budget Prepared for the U.S. House of Representatives Subcommittee on Labor-HHS-Education

More information

The Current Status of the Epidemiologic Transition

The Current Status of the Epidemiologic Transition The Current Status of the Epidemiologic Transition There are still job opportunities in Infectious Diseases and Tropical Medicine CAPT John W. Sanders, Medical Corps, US Navy Commanding Officer, Naval

More information

Pandemic Influenza Preparedness

Pandemic Influenza Preparedness Pandemic Influenza Preparedness Of the many health threats that we are preparing for, this is the one that we know will happen. Bruce G. Gellin, MD, MPH Director, National Vaccine Program Office Department

More information

Pandemic Preparedness

Pandemic Preparedness Pandemic Preparedness Disclosure Dr. Michael Braida is a full-time International SOS / MedAire employee Regional Medical Director Northern Seas based in Aberdeen MedAire Medical Director for Europe Medical

More information

Adjunct Faculty, Division of Epidemiology UC Berkeley School of Public Health. San Francisco Department of Public Health.

Adjunct Faculty, Division of Epidemiology UC Berkeley School of Public Health. San Francisco Department of Public Health. Infectious Disease Threats in the 21st Century: Prevention, Control, and Emergency Response Tomás J. Aragón, MD, DrPH Health Officer, City & County of San Francisco Director, Population Health Division

More information

Global Challenges of Pandemic and Avian Influenza. 19 December 2006 Keiji Fukuda Global influenza Programme

Global Challenges of Pandemic and Avian Influenza. 19 December 2006 Keiji Fukuda Global influenza Programme Global Challenges of Pandemic and Avian Influenza 19 December 2006 Keiji Fukuda Global influenza Programme Summary of Current H5N1 Situation 1997 First known outbreak infecting humans 18 people hospitalized

More information

Arbovirus Surveillance: Present and Future

Arbovirus Surveillance: Present and Future Arbovirus Surveillance: Present and Future Duane J Gubler, ScD, FAAAS, FIDSA, FASTMH Emeritus Professor Program in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Chairman, Global Dengue

More information

Emerging infectious disease: trends in the literature on SARS and H7N9 influenza

Emerging infectious disease: trends in the literature on SARS and H7N9 influenza Scientometrics (2015) 105:485 495 DOI 10.1007/s11192-015-1681-8 Emerging infectious disease: trends in the literature on SARS and H7N9 influenza Deqiao Tian 1 Tao Zheng 1 Received: 19 July 2015 / Published

More information

Evolution of influenza

Evolution of influenza Evolution of influenza Today: 1. Global health impact of flu - why should we care? 2. - what are the components of the virus and how do they change? 3. Where does influenza come from? - are there animal

More information

WHAT WILL WE LEARN FROM ESEI RESEARCH?

WHAT WILL WE LEARN FROM ESEI RESEARCH? WHAT WILL WE LEARN FROM ESEI RESEARCH? Mark Woolhouse University of Edinburgh WHAT WILL WE LEARN FROM ESEI RESEARCH? Dealing with diverse disease ecologies Diversity and generalisation Endemic diseases

More information

Emerging & re-emerging infections on the African Continent-the Public Health Aspect: Is Africa Prepared?

Emerging & re-emerging infections on the African Continent-the Public Health Aspect: Is Africa Prepared? Emerging & re-emerging infections on the African Continent-the Public Health Aspect: Is Africa Prepared? International Conference on (Re) Emerging Infectious Diseases, 12-14 March, African Union Commission,

More information

OIE Situation Report for Avian Influenza

OIE Situation Report for Avian Influenza OIE Situation Report for Avian Influenza Latest update: 08/05/2017 This report presents an overview of current disease events reported to the OIE by its Members. The objective is to describe what is happening

More information

Update August Questions & Answers on Middle East Respiratory Syndrome Coronavirus (MERS CoV)

Update August Questions & Answers on Middle East Respiratory Syndrome Coronavirus (MERS CoV) Update August 2014 - Questions & Answers on Middle East Respiratory Syndrome Coronavirus (MERS CoV) What is MERS-CoV? MERS-CoV is a coronavirus (CoV) which causes Middle East Respiratory Syndrome (MERS),

More information

Priorities for the global surveillance of pathogens in bats

Priorities for the global surveillance of pathogens in bats Priorities for the global surveillance of pathogens in bats Jonathan Epstein DVM, MPH Senior Research Scientist The Consortium for Conservation Medicine Institute of Medicine and National Research Council

More information

THE UNREGULATED AND INFORMAL TRADE IN WILDLIFE: IMPLICATIONS FOR BIODIVERSITY AND HEALTH

THE UNREGULATED AND INFORMAL TRADE IN WILDLIFE: IMPLICATIONS FOR BIODIVERSITY AND HEALTH THE UNREGULATED AND INFORMAL TRADE IN WILDLIFE: IMPLICATIONS FOR BIODIVERSITY AND HEALTH William B. Karesh Kristine Smith Marianne Asmüssen OIE Global Conference on Wildlife: Animal Health and Biodiversity

More information

INTERfering and Co-Evolving Prevention and Therapy (INTERCEPT) Proposers Day

INTERfering and Co-Evolving Prevention and Therapy (INTERCEPT) Proposers Day INTERfering and Co-Evolving Prevention and Therapy (INTERCEPT) Proposers Day Dr. Jim Gimlett, Program Manager DARPA Biological Technologies Office (BTO) April 28, 2016 Arlington, VA INTERCEPT Agenda INTERCEPT

More information

New Initiatives in Surveillance: The USAID EPT PREDICT Project

New Initiatives in Surveillance: The USAID EPT PREDICT Project New Initiatives in Surveillance: The USAID EPT PREDICT Project Stephen S. Morse Co-Director, PREDICT Columbia University & University of California, Davis IOM Symposium on Emerging Infections, Microbial

More information

Global Health Security: Preparedness and Response: can we do better and stay safe?

Global Health Security: Preparedness and Response: can we do better and stay safe? Global Health Security: Preparedness and Response: can we do better and stay safe? John Watson Health Protection Directorate, Public Health England Formerly Deputy Chief Medical Officer, Department of

More information

Centers for Disease Control and Prevention (CDC) FY 2009 Budget Request Summary

Centers for Disease Control and Prevention (CDC) FY 2009 Budget Request Summary Centers for Disease Control and Prevention (CDC) FY 2009 Budget Request Summary The President s FY 2009 Budget Request for the Centers for Disease Control and Prevention (CDC) discretionary funding is

More information

Global updates on avian influenza and tools to assess pandemic potential. Julia Fitnzer Global Influenza Programme WHO Geneva

Global updates on avian influenza and tools to assess pandemic potential. Julia Fitnzer Global Influenza Programme WHO Geneva Global updates on avian influenza and tools to assess pandemic potential Julia Fitnzer Global Influenza Programme WHO Geneva Pandemic Influenza Risk Management Advance planning and preparedness are critical

More information

AREAS OF CONCENTRATION

AREAS OF CONCENTRATION Dr. Shruti Mehta, Director The development of antibiotics, improved access to safe food, clean water, sewage disposal and vaccines has led to dramatic progress in controlling infectious diseases. Despite

More information

New Delhi International Ministerial Conference on Avian and Pandemic Influenza Dec 4-6th, 2007

New Delhi International Ministerial Conference on Avian and Pandemic Influenza Dec 4-6th, 2007 New Delhi International Ministerial Conference on Avian and Pandemic Influenza Dec 4-6th, 2007 Session IV Influenza Pandemic Preparedness Dr Paul R Gully Health Security and Environment, Geneva Avian Influenza

More information

WILDLIFE DISEASE - PRESENT YET EMERGING THREAT

WILDLIFE DISEASE - PRESENT YET EMERGING THREAT WILDLIFE DISEASE - PRESENT YET EMERGING THREAT Disease whether driven by pathogens, pollutants, genetics, or dietary deficiencies can threaten vulnerable wildlife populations as significantly as do overhunting

More information

Perspective. Where Do Emerging Pathogens Come from? Understanding the origins of pathogens will help us to combat emerging infectious diseases

Perspective. Where Do Emerging Pathogens Come from? Understanding the origins of pathogens will help us to combat emerging infectious diseases Where Do Emerging Pathogens Come from? Understanding the origins of pathogens will help us to combat emerging infectious diseases Mark E. J. Woolhouse nfectious diseases continue to impose a I huge global

More information

Combating Agent X: Accelerating Global Vaccine Production Against New Pandemic Threats

Combating Agent X: Accelerating Global Vaccine Production Against New Pandemic Threats Combating Agent X: Accelerating Global Vaccine Production Against New Pandemic Threats Dr. George Poste Chief Scientist, Complex Adaptive Systems Initiative and Del E. Webb Chair in Health Innovation Arizona

More information

Pandemic Influenza: Hype or Reality?

Pandemic Influenza: Hype or Reality? Pandemic Influenza: Hype or Reality? Leta Finch Executive Director, Higher Education Practice 2003 Arthur J. Gallagher & Co. Objectives Review key characteristics of influenza, including differences between

More information

Planning Informed by Epidemiological Simulation: The Geography of Avian Flu in Nigeria

Planning Informed by Epidemiological Simulation: The Geography of Avian Flu in Nigeria Planning Informed by Epidemiological Simulation: The Geography of Avian Flu in Nigeria Jeanne Fair, Ph.D. Biosecurity & Public Health Group (B-7) Los Alamos National Laboratory Slide 1 Geospatial Epidemiology

More information

2013 NEHA AEC July 9 11, One Health and All-Hazards: the New Environmental Health. Want this on you?

2013 NEHA AEC July 9 11, One Health and All-Hazards: the New Environmental Health. Want this on you? One Health and All-Hazards: the New Environmental Health Christopher Eddy, MPH, REHS, RS, M.B.A. (candidate) Erik Balster, MPH, REHS, RS July 11, 2013 Next best thing to the Cover of the Rolling Stone?

More information

Promoting Public Health Security Addressing Avian Influenza A Viruses and Other Emerging Diseases

Promoting Public Health Security Addressing Avian Influenza A Viruses and Other Emerging Diseases Promoting Public Health Security Addressing Avian Influenza A Viruses and Other Emerging Diseases Masaya Kato, WHO Viet Nam OIE Regional Workshop on Enhancing Influenza A viruses National Surveillance

More information

Influenza Surveillance Report

Influenza Surveillance Report Influenza Surveillance Report www.infectiousdisease.dhh.la.gov Week 5: 12/23/18-12/29/18 Influenza activity increased this week in Louisiana. Rhino/Enteroviruses, RSV, and Coronaviruses represent the majority

More information

100 Years Since 1918: Are We Ready for the Next Pandemic?

100 Years Since 1918: Are We Ready for the Next Pandemic? 100 Years Since 1918: Are We Ready for the Next Pandemic? Daniel B. Jernigan, MD MPH Director, Centers for Disease Control and Prevention January 9, 2018 Today s Agenda Remembering the 1918 pandemic Reviewing

More information

Pandemic and Data- Future Preparedness

Pandemic and Data- Future Preparedness 2016/SOM1/ECSG/DPS/028 Agenda Item: 4d Pandemic and Data- Future Preparedness Purpose: Information Submitted by: ICC Data Privacy Sub-Group Meeting Lima, Peru 25 February 2016 Pandemic and Data- Future

More information

Incidence of Seasonal Influenza

Incidence of Seasonal Influenza What Is All the Fuss? A Just-in in-time Primer on H1N1 Influenza A and Pandemic Influenza provided by the National Association of State EMS Officials May 1, 2009 Disclaimer This self-learning learning

More information

IS THE UK WELL PREPARED FOR A REPEAT OF THE 1918 INFLUENZA PANDEMIC?

IS THE UK WELL PREPARED FOR A REPEAT OF THE 1918 INFLUENZA PANDEMIC? Cambridge Judge Business School Centre for Risk Studies IS THE UK WELL PREPARED FOR A REPEAT OF THE 1918 INFLUENZA PANDEMIC? Dr Andrew Coburn Chief Scientist Cambridge Centre for Risk Studies 5 December

More information

Emerging Viral Diseases of Southeast Asia

Emerging Viral Diseases of Southeast Asia Emerging Viral Diseases of Southeast Asia Issues in Infectious Diseases Vol. 4 Series Editors Heinz Zeichhardt Brian W. J. Mahy Berlin Atlanta, Ga. Emerging Viral Diseases of Southeast Asia Volume Editor

More information

Occupational Infections: Risks for the Anesthesiologist

Occupational Infections: Risks for the Anesthesiologist Occupational Infections: Risks for the Anesthesiologist 2017 {Music} Dr. Alan Jay Schwartz: Hello. This is Alan Jay Schwartz, Editor-in-Chief of the American Society of Anesthesiologists 2017 Refresher

More information

Dr. Alejandro Schudel Fundación PROSAIA Argentina. 17 th IMS World Meat Congress Cape Town, South Africa, 7-10 September 2008

Dr. Alejandro Schudel Fundación PROSAIA Argentina. 17 th IMS World Meat Congress Cape Town, South Africa, 7-10 September 2008 Dr. Alejandro Schudel Fundación PROSAIA Argentina 17 th IMS World Meat Congress Cape Town, South Africa, 7-10 September 2008 The international scene. Hazards and opportunities: New challenges Past years

More information

ANALYZING AND MANAGING RISKS IN LIFE SCIENCES RESEARCH

ANALYZING AND MANAGING RISKS IN LIFE SCIENCES RESEARCH Practical Training Exercise ANALYZING AND MANAGING RISKS IN LIFE SCIENCES RESEARCH Based on the article by Siddique, N. et al. Sequence and phylogenetic analysis of highly pathogenic avian influenza H5N1

More information

Drivers of Infectious Disease: Connections Matter

Drivers of Infectious Disease: Connections Matter Drivers of Infectious Disease: Connections Matter Local conservation. Global health. William B. Karesh, DVM Executive Vice President for Health and Policy, EcoHealth Alliance President, OIE Working Group

More information

Where is the frontline in the battle against infectious diseases?

Where is the frontline in the battle against infectious diseases? Where is the frontline in the battle against infectious diseases? Scanning for fever in response to swine flu, Singapore HIV screening and counseling activities Cameroon Taiwanese hospital during SARS

More information

Avian influenza - current situation and future trends

Avian influenza - current situation and future trends Avian influenza - current situation and future trends Calogero Terregino OIE, FAO and National Reference Laboratory for Newcastle Disease and Avian Influenza, Istituto Zooprofilattico Sperimentale delle

More information

RISK OF WORLDWIDE PANDEMIC AND STATE OF PANDEMIC PREPAREDNESS: FOCUS ON INFLUENZA

RISK OF WORLDWIDE PANDEMIC AND STATE OF PANDEMIC PREPAREDNESS: FOCUS ON INFLUENZA RISK OF WORLDWIDE PANDEMIC AND STATE OF PANDEMIC PREPAREDNESS: FOCUS ON INFLUENZA David Nabarro United Nations System Influenza Coordinator February 4 th 2008 History: Disease Outbreaks and Pandemics Consequences

More information

CIDRAP Leadership Forum Infectious Disease BRIEFING

CIDRAP Leadership Forum Infectious Disease BRIEFING Center for Infectious Disease Research and Policy University of Minnesota CIDRAP Leadership Forum Infectious Disease BRIEFING August 22 nd, 2018 CLF BRIEFING HOT TOPICS 1. Ebola 2. Foodborne diseases 3.

More information

Overview of the Influenza Virus

Overview of the Influenza Virus Overview of the Influenza Virus Victor C. Huber, Ph.D. September 24, 2015 victor.huber@usd.edu General Features of Influenza Virus Infections Clinical Features of Influenza Sudden onset of symptoms Incubation

More information

Introduction to Innovative Disease Surveillance

Introduction to Innovative Disease Surveillance HANDBOOK Introduction to Innovative Disease Surveillance IN PARTNERSHIP WITH INTRO This course is designed to provide a refresher of the basic disease surveillance skills and information you need as a

More information

Size doesn t matter! Even small-medium sized zoos can build BIG relationships that lead to comprehensive foreign animal disease outbreak preparedness

Size doesn t matter! Even small-medium sized zoos can build BIG relationships that lead to comprehensive foreign animal disease outbreak preparedness Size doesn t matter! Even small-medium sized zoos can build BIG relationships that lead to comprehensive foreign animal disease outbreak preparedness Julie Barnes, Director of Animal Health Rachel Ritchason,

More information

H1N1 Response and Vaccination Campaign

H1N1 Response and Vaccination Campaign 2009-2010 H1N1 Response and Vaccination Campaign Stephanie A. Dopson, MSW, MPH, ScD. Candidate Influenza Coordination Unit Centers for Disease Control and Prevention CDC H1N1 Response In late March and

More information

- STATEMENT OF WORK - Task Authorization (TA) - 38

- STATEMENT OF WORK - Task Authorization (TA) - 38 1. NUMBER TITLE OF TASK AUTHORIZATION TA Broad spectrum antivirals against RNA viruses which block cellular entry. 2. VALIDATION OF SCOPE OF CONTRACT The following task(s), as written in the SOW of the

More information

Public health relevant virological features of Influenza A(H7N9) causing human infection in China

Public health relevant virological features of Influenza A(H7N9) causing human infection in China Public health relevant virological features of Influenza A(H7N9) causing human infection in China Address requests about publications of the WHO Regional Office for Europe to: Publications WHO Regional

More information

Current CEIRS Program

Current CEIRS Program History The influenza program at St. Jude has a long, distinguished history as a world-class leader in the study of the origins, evolution, and pathogenesis of influenza viruses. Based on this expertise,

More information

Questions and Answers

Questions and Answers Questions and Answers Recommended composition of influenza virus vaccines for use in the southern hemisphere 2016 influenza season and development of candidate vaccine viruses for pandemic preparedness

More information

Regional Initiative on Environment and Health. Work Plan Thematic Working Group (TWG) on Climate Change, Ozone Depletion and Ecosystem Changes

Regional Initiative on Environment and Health. Work Plan Thematic Working Group (TWG) on Climate Change, Ozone Depletion and Ecosystem Changes Regional Initiative on Environment and Health World Health Organization United Nations Environment Programme Ministerial Regional Forum on Environment and Health in Southeast and East Asian Countries August

More information

IN VIVO STUDIES ON VIRAL VIRULENCE

IN VIVO STUDIES ON VIRAL VIRULENCE IN VIVO STUDIES ON VIRAL VIRULENCE M.Phil student: Emily TSUI Supervisor: Professor Paul K.S Chan Department of Microbiology, CUHK Date: 15th Dec, 2014 Viral Virulence Capacity of a virus to cause disease

More information

Influenza & Other Respiratory Viruses Update

Influenza & Other Respiratory Viruses Update Influenza & Other Respiratory Viruses Update 2013-2014 Pete Shult, PhD. Director, Communicable Disease Division and Emergency Response Erik Reisdorf, MPH M (ASCP) CM Team Lead, Virology Laboratory WCLN

More information